comparemela.com

Latest Breaking News On - Coheru immuno - Page 1 : comparemela.com

Surface Oncology : Coherus Completes Surface Oncology Acquisition - Form 8-K -Today at 09:25 am

Coherus Completes Surface Oncology Acquisition - Clinical-stage product candidates, casdozokitug and CHS-114, significantly advance .

United statesCoheru immunoDenny lanfearMarek ciszewskiJodi sieversCoherus biosciencesCoherus biosciences incGoodwin procterExchange commissionWedbush securities incVp corporate communicationsLatham watkinsArnold porter kaye scholerShanghai junshi biosciences ltdSurface oncology incExchange commission on

Coherus Completes Surface Oncology Acquisition

– Clinical-stage product candidates, casdozokitug and CHS-114, significantly advancenext-generation immuno-oncology portfolio focused on the tumor microenvironment – – I-O combinations will.

United statesMarek ciszewskiDenny lanfearJodi sieversCoheru immunoCoherus biosciencesCoherus biosciences incExchange commissionGoodwin procterSurface oncology incVp corporate communicationsLatham watkinsShanghai junshi biosciences ltdArnold porter kaye scholerWedbush securities incExchange commission on

vimarsana © 2020. All Rights Reserved.